reaxys medicinal chemistry nov20 2014

27
REAXYS MEDICINAL CHEMISTRY 1 Drug Repositioning (Repurposing) Christine Flemming [email protected] Webinar held November 20, 2014

Upload: reaxys

Post on 10-Jul-2015

423 views

Category:

Science


4 download

TRANSCRIPT

Page 1: Reaxys Medicinal Chemistry Nov20 2014

REAXYS MEDICINAL CHEMISTRY

1

Drug Repositioning (Repurposing)

Christine Flemming

[email protected]

Webinar held November 20, 2014

Page 2: Reaxys Medicinal Chemistry Nov20 2014

2

DRUG REPURPOSING

ScopusReaxys

Literature search shows increasing interest in drug repurposing

Page 3: Reaxys Medicinal Chemistry Nov20 2014

“BIG PHARMA” DRUG DISCOVERY IN THE 21ST CENTURY

The Problem: The pharmaceutical industry is short of new drugs.

In the 2nd part of the 20th century, about 50-60 new drugs (NCEs) were approved by

the FDA every year.

In contrast, in 2002, a historical low of 17 NCEs were approved (in 2001, 24 NCEs, in

2000, 27 NCEs, in 2003, 21 NCEs).

RESEARCH COST

research costs for a

new drug are

estimated to be in

the $1-1.5 Bi. range.

Considering all high-

profile failures in

recent drug discovery,

this figure is unlikely

to drop substantially

Page 4: Reaxys Medicinal Chemistry Nov20 2014

4

DRUG REPURPOSING

• Fewer safety concerns

• Saves money

• Less time to get a drug to market

• New opportunities

Page 5: Reaxys Medicinal Chemistry Nov20 2014

5

Reaxys Reaxys Medicinal Chemistry

TWO DATABASES

Page 6: Reaxys Medicinal Chemistry Nov20 2014

6

Reaxys

TWO DATABASES

Searches over 50 million unique substances

Physical properties

Spectra data

Reaction information

Page 7: Reaxys Medicinal Chemistry Nov20 2014

7

Reaxys Medicinal Chemistry

TWO DATABASES

Contains over 5 million substances

25 million biological datapoints

from over 5,000 journals

and over 90,000 Patents

Page 8: Reaxys Medicinal Chemistry Nov20 2014

COMBINED USER INTERFACE

Page 9: Reaxys Medicinal Chemistry Nov20 2014

9

ESSENTIAL INFORMATION: 100+ EXPERIMENTAL FIELDS

Reaxys Medicinal Chemistry excerpts all the relevant Quantitative data

Page 10: Reaxys Medicinal Chemistry Nov20 2014

10

ESSENTIAL INFORMATION

Compound

Chemical structure ,Name, code, synonym of compound

Druggable target

Explore Target affinity patterns of chemical compounds

In vitro and Cell Based assays

In vitro assays (binding, second messenger etc..) and Cell based assays for example

: Aggregation, Angiogenesis, Apoptosis, Cell differentiation, Cellular Cycle,

Chondrogenesis

Animal models disease

ovariectomized rat in osteoporosis, treatment of glaucoma, Xenografted animals

with tumors to test and develop antineplastic drugs

Pharmacokinetic and ADME Properties

Metabolic stability, Intrinsic clearance, Half life of elimination, Bioavailability, In

vivo Clearance

Toxicity

Cytotoxicity, cardiotoxicity, chronic toxicity

Page 11: Reaxys Medicinal Chemistry Nov20 2014

11

Reaxys Medicinal Chemistry can be used for:

• The assessment of new drugs

• Lead identification

• Lead optimization

• Drug repurposing

Page 12: Reaxys Medicinal Chemistry Nov20 2014

DRUG PROFILE

12

KETAMINE

Used as an anesthetic for the past 50 years

Over the last 5 years there has been increased interest in studying it’s use in mood disorders, as a vasodilator, and as an antinflammatory, among other things.

Use Reaxys Medicinal Chemistry to get a profile of Ketamine and related drugs

Page 13: Reaxys Medicinal Chemistry Nov20 2014

13

Page 14: Reaxys Medicinal Chemistry Nov20 2014

DRUG PROFILE

14

KETAMINE

Page 15: Reaxys Medicinal Chemistry Nov20 2014

EXAMPLE OF THE RAW DATA

15

Page 16: Reaxys Medicinal Chemistry Nov20 2014

16

EXPORT THE DATA

Page 17: Reaxys Medicinal Chemistry Nov20 2014

DRUG PROFILE

17

KETAMINE

Used as an anesthetic for the past 50 years

Over the last 5 years there has been increased interest in studying it’s use in mood disorders, as a vasodilator, and as an antinflammatory, among other things.

Use Reaxys Medicinal Chemistry to get a profile of Ketamine and related drugs

Page 18: Reaxys Medicinal Chemistry Nov20 2014

18

FIND SUBSTANCES SIMILAR TO KETAMINE

CAN THESE SUBSTANCES SUGGEST OTHER POSSIBLE USES FOR KETAMINE?

Page 19: Reaxys Medicinal Chemistry Nov20 2014

FOCUS ON SUBSTANCES WITH DIFFERENT TARGET DATA

19

Compare to Ketamine targets

Show structures

Page 20: Reaxys Medicinal Chemistry Nov20 2014

20

FIND OUT MORE ABOUT THE KETAMINE NMDA TARGET

Use these 2 fields for the query

Sort the Agonist column in descending order to view the most active substances.

View Effects/Substances

WHAT OTHER SUBSTANCES BIND TO THIS TARGET? CAN I SEE JUST THE AGONISTS?

Page 21: Reaxys Medicinal Chemistry Nov20 2014

21

View the data for these substances. For example:

Note: This one should be the last one in the list.

Page 22: Reaxys Medicinal Chemistry Nov20 2014

SEARCH BY EFFECT

22

MARKETED DRUGS

Look for drugs that have antiparasitic/antiprotozoal activity and are currently on the market. Which targets are involved in their activity?

Page 23: Reaxys Medicinal Chemistry Nov20 2014

23

Antihypertensive

vasodilator Cough suppressant

antioxident

Some substances in the list are marketed for other things, such as:

Page 24: Reaxys Medicinal Chemistry Nov20 2014

WHICH TARGETS ARE RESPONSIBLE FOR THE ANTIPARASITIC/ANTIPROTOZOAL ACTIVITY?

24

Change the Heatmap view

View the data

Page 25: Reaxys Medicinal Chemistry Nov20 2014

25

WHICH SUBSTANCES HAD THE HIGHEST PX VALUES?

WHAT BIOLOGICAL SPECIES WERE THEY TESTED ON?

Change the Heatmap view

Filter for pX >5.9

Limit the view to selected products that may warrant further investigation

Used in eye drops for eye infections.

Used for cutaneous T-cell lymphoma

A Natural Product for use in for a variety of illnesses

Page 26: Reaxys Medicinal Chemistry Nov20 2014

SELECT DATA TO ADD TO A REPORT

26

Switch to Substances view

View Data Availability

Mouse over the data and select the data you want to add to a report.

View and manage the Report by clicking the Report button.

Page 27: Reaxys Medicinal Chemistry Nov20 2014

THANK YOU!

ANY QUESTIONS?

CONTACT ME: [email protected]

27